OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies
Urvi A. Shah, Elaine Y. Chung, Orsi Giricz, et al.
Blood (2018) Vol. 132, Iss. 14, pp. 1507-1518
Open Access | Times Cited: 76
Urvi A. Shah, Elaine Y. Chung, Orsi Giricz, et al.
Blood (2018) Vol. 132, Iss. 14, pp. 1507-1518
Open Access | Times Cited: 76
Showing 1-25 of 76 citing articles:
The Role of CREBBP/EP300 and Its Therapeutic Implications in Hematological Malignancies
Yu Zhu, Zi Wang, Yanan Li, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1219-1219
Open Access | Times Cited: 48
Yu Zhu, Zi Wang, Yanan Li, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1219-1219
Open Access | Times Cited: 48
Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockade
Daniel A. Rauch, Kevin C. Conlon, Murali Janakiram, et al.
Blood (2019) Vol. 134, Iss. 17, pp. 1406-1414
Open Access | Times Cited: 88
Daniel A. Rauch, Kevin C. Conlon, Murali Janakiram, et al.
Blood (2019) Vol. 134, Iss. 17, pp. 1406-1414
Open Access | Times Cited: 88
CCR4 as a Therapeutic Target for Cancer Immunotherapy
Osamu Yoshie
Cancers (2021) Vol. 13, Iss. 21, pp. 5542-5542
Open Access | Times Cited: 83
Osamu Yoshie
Cancers (2021) Vol. 13, Iss. 21, pp. 5542-5542
Open Access | Times Cited: 83
Whole-genome landscape of adult T-cell leukemia/lymphoma
Yasunori Kogure, Takuro Kameda, Junji Koya, et al.
Blood (2021) Vol. 139, Iss. 7, pp. 967-982
Open Access | Times Cited: 65
Yasunori Kogure, Takuro Kameda, Junji Koya, et al.
Blood (2021) Vol. 139, Iss. 7, pp. 967-982
Open Access | Times Cited: 65
The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management
Enrica Marchi, Owen A. O’Connor
CA A Cancer Journal for Clinicians (2019) Vol. 70, Iss. 1, pp. 47-70
Open Access | Times Cited: 62
Enrica Marchi, Owen A. O’Connor
CA A Cancer Journal for Clinicians (2019) Vol. 70, Iss. 1, pp. 47-70
Open Access | Times Cited: 62
Evolution of retrovirus-infected premalignant T-cell clones prior to adult T-cell leukemia/lymphoma diagnosis
Aileen Rowan, Richard Dillon, Aviva Witkover, et al.
Blood (2020) Vol. 135, Iss. 23, pp. 2023-2032
Open Access | Times Cited: 62
Aileen Rowan, Richard Dillon, Aviva Witkover, et al.
Blood (2020) Vol. 135, Iss. 23, pp. 2023-2032
Open Access | Times Cited: 62
How I treat adult T-cell leukemia/lymphoma
Lucy Cook, Adrienne A. Phillips
Blood (2020) Vol. 137, Iss. 4, pp. 459-470
Open Access | Times Cited: 62
Lucy Cook, Adrienne A. Phillips
Blood (2020) Vol. 137, Iss. 4, pp. 459-470
Open Access | Times Cited: 62
Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma
Makoto Yamagishi, Miyuki Kubokawa, Yuta Kuze, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 51
Makoto Yamagishi, Miyuki Kubokawa, Yuta Kuze, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 51
Clinical and therapeutic significance of genetic profiling in adult T-cell leukemia/lymphoma
Yasunori Kogure, Keisuke Kataoka
Leukemia Research (2025) Vol. 151, pp. 107676-107676
Closed Access
Yasunori Kogure, Keisuke Kataoka
Leukemia Research (2025) Vol. 151, pp. 107676-107676
Closed Access
Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis by using the new oral demethylating agent OR-2100
Tatsuro Watanabe, Satoshi Yamashita, Hiroshi Ureshino, et al.
Blood (2020) Vol. 136, Iss. 7, pp. 871-884
Open Access | Times Cited: 35
Tatsuro Watanabe, Satoshi Yamashita, Hiroshi Ureshino, et al.
Blood (2020) Vol. 136, Iss. 7, pp. 871-884
Open Access | Times Cited: 35
The tyrosine kinase KDR is essential for the survival of HTLV-1-infected T cells by stabilizing the Tax oncoprotein
Suchitra Mohanty, Sujit Suklabaidya, Alfonso Lavorgna, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Suchitra Mohanty, Sujit Suklabaidya, Alfonso Lavorgna, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Targeted deep sequencing reveals clonal and subclonal mutational signatures in Adult T-cell leukemia/lymphoma and defines an unfavorable indolent subtype
Ambroise Marçais, Ludovic Lhermitte, Maria Artesi, et al.
Leukemia (2020) Vol. 35, Iss. 3, pp. 764-776
Closed Access | Times Cited: 31
Ambroise Marçais, Ludovic Lhermitte, Maria Artesi, et al.
Leukemia (2020) Vol. 35, Iss. 3, pp. 764-776
Closed Access | Times Cited: 31
Distinctive genomic features of human T-lymphotropic virus type 1-related adult T-cell leukemia-lymphoma in Western populations
Caroline S. Myers, Eli S. Williams, Carlos Barrionuevo Cornejo, et al.
Haematologica (2024)
Open Access | Times Cited: 3
Caroline S. Myers, Eli S. Williams, Carlos Barrionuevo Cornejo, et al.
Haematologica (2024)
Open Access | Times Cited: 3
Epidemiology and survival trend of adult T‐cell leukemia/lymphoma in the United States
Urvi A. Shah, Nishi Shah, Baozhen Qiao, et al.
Cancer (2019) Vol. 126, Iss. 3, pp. 567-574
Open Access | Times Cited: 29
Urvi A. Shah, Nishi Shah, Baozhen Qiao, et al.
Cancer (2019) Vol. 126, Iss. 3, pp. 567-574
Open Access | Times Cited: 29
The peripheral T-cell lymphomas: an unusual path to cure
Helen Ma, Enrica Marchi, Owen A. O’Connor
The Lancet Haematology (2020) Vol. 7, Iss. 10, pp. e765-e771
Closed Access | Times Cited: 26
Helen Ma, Enrica Marchi, Owen A. O’Connor
The Lancet Haematology (2020) Vol. 7, Iss. 10, pp. e765-e771
Closed Access | Times Cited: 26
Real-World Data on Adult T-Cell Leukemia/Lymphoma in Latin America: A Study From the Grupo de Estudio Latinoamericano de Linfoproliferativos
Luis Malpica, Daniel Enríquez, Denisse Castro, et al.
JCO Global Oncology (2021), Iss. 7, pp. 1151-1166
Open Access | Times Cited: 21
Luis Malpica, Daniel Enríquez, Denisse Castro, et al.
JCO Global Oncology (2021), Iss. 7, pp. 1151-1166
Open Access | Times Cited: 21
Quantification of T cell clonality in human T cell leukaemia virus type-1 carriers can detect the development of adult T cell leukaemia early
Sonia N Wolf, Jana Haddow, Claire Greiller, et al.
Blood Cancer Journal (2021) Vol. 11, Iss. 3
Open Access | Times Cited: 19
Sonia N Wolf, Jana Haddow, Claire Greiller, et al.
Blood Cancer Journal (2021) Vol. 11, Iss. 3
Open Access | Times Cited: 19
Clonal Selection and Evolution of HTLV-1-Infected Cells Driven by Genetic and Epigenetic Alteration
Makoto Yamagishi, Yutaka Suzuki, Toshiki Watanabe, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 587-587
Open Access | Times Cited: 13
Makoto Yamagishi, Yutaka Suzuki, Toshiki Watanabe, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 587-587
Open Access | Times Cited: 13
Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma
Abdul Hamid Bazarbachi, Daniel Reef, Hiba Narvel, et al.
Clinical Hematology International (2023) Vol. 5, Iss. 2-3, pp. 78-91
Open Access | Times Cited: 7
Abdul Hamid Bazarbachi, Daniel Reef, Hiba Narvel, et al.
Clinical Hematology International (2023) Vol. 5, Iss. 2-3, pp. 78-91
Open Access | Times Cited: 7
Clinical characteristics, genetic alterations, and prognosis of adult T-cell leukemia/lymphoma: an 11-year multicenter retrospective study in China
Luting Luo, Yanxin Chen, Zhengjun Wu, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 4, pp. 1649-1661
Open Access | Times Cited: 2
Luting Luo, Yanxin Chen, Zhengjun Wu, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 4, pp. 1649-1661
Open Access | Times Cited: 2
Peripheral T-cell lymphoma: From biology to practice to the future
Owen A. O’Connor, Helen Ma, Jason Yongsheng Chan, et al.
Cancer Treatment Reviews (2024) Vol. 129, pp. 102793-102793
Closed Access | Times Cited: 2
Owen A. O’Connor, Helen Ma, Jason Yongsheng Chan, et al.
Cancer Treatment Reviews (2024) Vol. 129, pp. 102793-102793
Closed Access | Times Cited: 2
ETS1 Function in Leukemia and Lymphoma
Rebecca A. Luchtel
Advances in experimental medicine and biology (2024), pp. 359-378
Closed Access | Times Cited: 2
Rebecca A. Luchtel
Advances in experimental medicine and biology (2024), pp. 359-378
Closed Access | Times Cited: 2
PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma
Elaine Y. Chung, Yun Mai, Urvi A. Shah, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 12, pp. 3589-3601
Open Access | Times Cited: 21
Elaine Y. Chung, Yun Mai, Urvi A. Shah, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 12, pp. 3589-3601
Open Access | Times Cited: 21
Genetic profile of adult T‐cell leukemia/lymphoma in Okinawa: Association with prognosis, ethnicity, and HTLV‐1 strains
Shugo Sakihama, Kazuho Morichika, Rumiko Saito, et al.
Cancer Science (2021) Vol. 112, Iss. 3, pp. 1300-1309
Open Access | Times Cited: 16
Shugo Sakihama, Kazuho Morichika, Rumiko Saito, et al.
Cancer Science (2021) Vol. 112, Iss. 3, pp. 1300-1309
Open Access | Times Cited: 16
Latency Reversing Agents: Kick and Kill of HTLV-1?
Annika P. Schnell, Stephan Kohrt, Andrea K. Thoma-Kreß
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5545-5545
Open Access | Times Cited: 16
Annika P. Schnell, Stephan Kohrt, Andrea K. Thoma-Kreß
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5545-5545
Open Access | Times Cited: 16
